MatriSys Bioscience

About:

MatriSys Bio is a clinical stage Specialty Biopharmaceutical Company.

Top Investors: Tech Coast Angels, Mesa Verde Venture Partners, Primer Capital, Baker & Eastlack Ventures

Description:

MatriSys sees commercialization paths for its intellectual property in topical dermatology therapeutics, cosmetics, and skin care. The company’s lead live biologic therapeutic is currently in Phase I/II clinical trials targeting atopic dermatitis (commonly referred to as AD or eczema) patients.

Total Funding Amount:

$4.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

La Jolla, California, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)matrisysbio.com

Founders:

Richard Gallo

Number of Employees:

1-10

Last Funding Date:

2021-03-11

IPO Status:

Private

Industries: